Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRETERM AFRICA STUDY
PACTR202502489638730Phase 4Recruiting
- Sponsor
- Indiana University Office for Research Administration
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, open-label trial of caffeine in respiratory distress syndrome (RDS) and preterm birth, sponsored by Indiana University Office for Research Administration. Primary endpoint: Survival. Started Jan 2025; status: recruiting.
02
Drugs
caffeine
03
Conditions
respiratory distress syndrome (RDS)preterm birth
Beyond the preview
Go deeper on PACTR202502489638730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502489638730.